Joseph R. Osborne, M.D, Ph.D.

Founder, Rad Health Equity
Chief, Molecular Imaging and Therapeutics, Weill Cornell Medicine

Joseph Osborne M.D., Ph.D. is the Chief of Molecular Imaging and Therapeutics and a Professor of Radiology at Weill Cornell Medicine. He also serves as an Attending Radiologist at NewYork-Presbyterian/Weill Cornell Medicine.

Dr. Osborne earned his M.D. from Columbia College of Physicians and Surgeons and his Ph.D. in Biochemistry from Columbia’s Graduate School of Arts and Sciences in New York, NY. He completed an internship in Internal Medicine at the Washington Hospital Center in Washington, D.C., followed by residency training in Diagnostic Radiology at Columbia Presbyterian Hospital. He then pursued fellowship training in Nuclear Medicine and completed post-doctoral work at Memorial Sloan Kettering Cancer Center in New York, NY.

As the Director of the Rad Health Equity lab, Dr. Osborne focuses on advancing equitable and cost-effective diagnostics, theranostics, and precision medicine. He was the principal investigator on an NIH Academic Industrial Partnership RO1 grant titled “A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use” and led the Dean’s Health Disparity Research Award project, “Prostate Cancer Health Impact Program (pCHIP).”

Currently, Dr. Osborne is the Assistant Director for Clinical Trial Participation at the Meyer Cancer Center, where he is working on strengthening the clinical trials infrastructure through the Office of Community Outreach and Engagement.

Recommended